Hester Biosciences Ltd Q3 FY23 consolidated net profit jumps to Rs. 11.18 crores

Hester Biosciences Limited has reported Consolidated financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 79.335 crores during the period ended December 31, 2022 as compared to Rs. 77.602 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 11.186 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 6.942 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 14.29 for the period ended December 31, 2022 as compared to Rs. 7.77 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹79.335 crs	₹77.602 crs	2.23%
Net Profit	₹11.186 crs	₹6.942 crs	61.14%
EPS	₹14.29	₹7.77	83.91%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.79.335 crores during the period ended December 31, 2022 as compared to Rs.58.466 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.11.186 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.8.484 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.14.29 for the period ended December 31, 2022 as compared to Rs.9.79 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹79.335 crs	₹58.466 crs	35.69%
Net Profit	₹11.186 crs	₹8.484 crs	31.85%
EPS	₹14.29	₹9.79	45.97%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.210.755 crores during the 9 Months period ended December 31, 2022 as compared to Rs.185.086 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.22.096 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.31.597 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.26.24 for the 9 Months period ended December 31, 2022 as compared to Rs.35.83 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹210.755 crs	₹185.086 crs	13.87%
Net Profit	₹22.096 crs	₹31.597 crs	-30.07%
EPS	₹26.24	₹35.83	-26.77%

Shares of Hester Biosciences Limited was last trading in BSE at Rs. 1776.05 as compared to the previous close of Rs. 1747.05. The total number of shares traded during the day was 20 in over 16 trades.

The stock hit an intraday high of Rs. 1787.00 and intraday low of 1765.05. The net turnover during the day was Rs. 35577.00.

Source : Equity Bulls

Keywords

HesterBiosciences Q3FY23 9MFY23 ResultUpdate